Immediate Impact
62 standout
Citing Papers
Emerging challenges in antimicrobial resistance: implications for pathogenic microorganisms, novel antibiotics, and their impact on sustainability
2024 Standout
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
Works of Aileen David-Wang being referenced
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Aileen David-Wang | 125 | 148 | 43 | 118 | 14 | 328 | |
| Chris M. Parker | 228 | 88 | 9 | 53 | 10 | 352 | |
| Madeline King | 36 | 59 | 17 | 129 | 17 | 321 | |
| Carolina Bayona | 206 | 61 | 20 | 9 | 19 | 358 | |
| Mary E. Mattar | 151 | 15 | 32 | 70 | 8 | 338 | |
| Samah Awad | 51 | 29 | 27 | 57 | 27 | 370 | |
| David Vaughan | 116 | 52 | 15 | 63 | 19 | 358 | |
| E. Williams | 229 | 33 | 5 | 99 | 19 | 354 | |
| Norma J. Goodwin | 24 | 59 | 28 | 48 | 18 | 280 | |
| Paschalina Kontou | 133 | 38 | 8 | 14 | 12 | 260 | |
| Eva Susanne Dietrich | 78 | 34 | 55 | 18 | 21 | 362 |
All Works
Login with ORCID to disown or claim papers
Loading papers...